HLS Therapeutics Inc
(TSX:HLS)
C$
4.42
-0.050 (-1.12%)
Market Cap: 138.24 Mil
Enterprise Value: 182.98 Mil
PE Ratio: 0
PB Ratio: 1.72
GF Score: 62/100 HLS Therapeutics Inc (TSX:HLS) Transcripts
- 1